ArticlePloS one2024

Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer's disease (BenfoTeam).

Howard H Feldman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.